Noticias de HIMS_US
Noticias del mercado
Últimas noticias sobre HIMS_US — 906 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Hims & Hers Health recently prepared for potential U.S. regulatory changes on peptide compounding by acquiring a California peptide facility and beginning ingredient testing, while also expanding Hers branded services into the U.K. hair loss market and launching Hers in Australia. The build out of peptide manufacturing, combined with clinician led programs like Hers Hair and new Australian reach, highlights management’s focus on owning more of the care and supply chain across higher...
Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. -…
View the basic HIMS option chain and compare options of Hims & Hers Health, Inc. on Yahoo Finance.
/PRNewswire/ -- - ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 2, 2026 to file lead plaintiff...
/PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC
NUEVA YORK, 15 de octubre de 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, una empresa reconocida a nivel nacional
San Francisco, California--(Newsfile Corp. - October 15, 2026) - Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business misconduct.
Hims & Hers chief legal officer sells $100,576 in stock By Investing.com
Form 4 Hims Hers Health Inc: Soleil Boughton (CLO) For: 14 October
US FDA takes step to change peptide compounding policy
Página 4 de 46